Operative lengthening of the humerus: indications, benefits, and complications.

The purpose of this study was to determine the benefits and risks of humeral lengthening procedures. Distraction osteogenesis was performed in 19 humeri on 16 patients (9 males, 7 females). The mean age at the time of lengthening was 11.5 years (range 3-24 years) and average follow-up was 8.7 years (range 2-21 years). Etiologies for short humeri included infection in six patients, congenital anomaly in six patients, unicameral bone cysts involving the physis in five patients, and posttraumatic growth disturbance in two patients. The average lengthening was 5 cm. The benefits from humeral lengthening include increased performance in daily activities, improved sports performance, and significantly better self-image. Complications included temporary radial nerve palsy in three cases, drainage from the pin tracts in two cases, elbow flexion contracture in three cases, and late humerus fracture in two cases. All the complications resolved over time and did not affect the outcome. Eleven lengthening procedures were not associated with any complications. Although the humerus is surrounded by complex neurovascular structures and muscles, humerus lengthening provided satisfactory results with temporary minor complications.

The correction of ulnar claw fingers: a follow-up study comparing the extensor-to-flexor with the palmaris longus 4-tailed tendon transfer in patients with leprosy.

PURPOSE: The extensor to flexor 4-tailed tendon transfer (EF4T) and the palmaris longus 4-tailed tendon transfer (PL4T) are 2 surgical procedures used to correct intrinsic paralysis of the hand in leprosy. The EF4T traditionally is the more common procedure and requires the transfer of a wrist extensor muscle. The PL4T requires the transfer of the palmaris longus and morbidity is expected to be lower. A follow-up study was performed to determine whether the clinical outcome of the PL4T is superior to the EF4T procedure in leprosy patients with ulnar claw fingers that are considered mobile before surgery. METHODS: Fifty-five patients presented 65 affected hands, of which 40 hands had the PL4T and 25 had the EF4T procedure. Each hand was assessed before surgery and at follow-up evaluation by predetermined angle measurements, standardized photographs, mechanical function, and patient satisfaction. Each hand was given an overall technical grade according to previously published standards. RESULTS: After an average follow-up period of 33 months there was no statistically significant difference in the technical outcome or patient satisfaction between the 2 tendon transfer procedures. CONCLUSIONS: Whenever the palmaris longus is available it may be considered to be the motor tendon of choice to undertake a many-tailed procedure for claw finger reconstruction in mobile hands paralyzed by leprosy. The palmaris longus should be considered as a possible motor tendon when correcting intrinsic muscle paralysis of the hand.

Synovial chondromatosis of the foot.

Synovial chondromatosis rarely occurs in the foot. Five patients with synovial chondromatosis in the foot were treated with excision. There were four men and one woman with a mean age of 37 years (range, 19-58 years). Mineral densities adjacent to the joint were seen on radiographs of all patients. Synovial chondromatosis occurred in the calcaneocuboid, tibiotalar, naviculocuneiform, and metatarsophalangeal joints. A painful mass was the common initial presentation in all patients. The patients were followed up for an average of 5 years (range, 3-16 years) after arthrotomy and excision. All patients were relieved of symptoms and retained normal function. There was no clinical or radiographic evidence of recurrence.

Novel translocation (9;12)(q22;q24) in secondary chondrosarcoma arising from hereditary multiple exostosis.

We report a new translocation in a patient with a history of hereditary multiple exostosis (HME) who developed a recurrent grade I chondrosarcoma involving the sacrum and retroperitoneum. Karyotypic analysis of the tumor revealed a sole chromosome abnormality t(9;12)(q22;q24.3). To our knowledge, this translocation has not been previously identified in either chondrosarcoma, HME, or related tumor types. Our novel translocation may be related to the sarcomatous degeneration of the pre-existing exostosis.